VitaCell™ for CAR-T
Oncology (CAR-T Cell Delivery)
Key Facts
About Likarda
Likarda is a private, revenue-generating biotech company founded in 2012 that operates as a technology platform and services partner. Its patented Core-Shell Spherification® (CSS®) hydrogel encapsulation platform is designed to protect therapeutic payloads, enable controlled release, and improve outcomes for cell therapies, biologics, and small molecules. The company has built a portfolio of branded solutions (e.g., ViscoCell™, EnduraCell™, LiberaCell™, NovoSphere™) with demonstrated preclinical success and is scaling its capabilities, including launching proprietary equipment and an AI-driven formulation platform in 2025. Likarda's business model centers on partnering with and providing enabling technologies to other therapeutic developers.
View full company profile